Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

7.1%

3 terminated/withdrawn out of 42 trials

Success Rate

85.7%

-0.8% vs industry average

Late-Stage Pipeline

29%

12 trials in Phase 3/4

Results Transparency

0%

0 of 18 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

N/A
10(31.3%)
Phase 2
10(31.3%)
Phase 4
8(25.0%)
Phase 3
4(12.5%)
32Total
N/A(10)
Phase 2(10)
Phase 4(8)
Phase 3(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (42)

Showing 20 of 42 trials
NCT07536373Phase 3Not Yet Recruiting

Colchicine in Chronic Limb-Threatening Ischemia

Role: collaborator

NCT07488052Recruiting

Home-based Outpatient Multicenter Evaluation Using Electrocardiogram (HOME-ECG)

Role: collaborator

NCT07252128Not ApplicableEnrolling By Invitation

Effectiveness of Brain Dynamic Audio Stimulation for Improving Insomnia and Sleep Cycles in Healthcare Professionals: A Pilot Study

Role: lead

NCT06069141Not ApplicableRecruiting

Comparisons of Treatment Responses of Early Syphilis to Benzathine Penicillin G With or Without Doxycycline

Role: collaborator

NCT07091942Recruiting

Curative Therapy After Atezolizumab and Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma

Role: collaborator

NCT04030429Phase 2Terminated

Crizotinib in c-MET Mutation Metastatic/Recurrent/Persistent Endometrial Cancer

Role: collaborator

NCT06772194Recruiting

Taiwan Post-Stroke Disability Study

Role: collaborator

NCT06903273Phase 2Not Yet Recruiting

Neoadjuvant Tislelizumab, Gemcitabine, Cisplatin and S-1 for Resectable High-risk Cholangiocarcinoma

Role: collaborator

NCT03753074Phase 4Active Not Recruiting

Effectiveness of TAF in Reducing Clinical Events in CHB Patients Beyond Treatment Indications by Current Guidelines

Role: collaborator

NCT04619082Phase 4Active Not Recruiting

TAF to Prevent HBV Reactivation in Cancer Patients

Role: collaborator

NCT03024684Phase 4Active Not Recruiting

Statin for Preventing Hepatocellular Carcinoma Recurrence After Curative Treatment

Role: collaborator

NCT05576714Unknown

Investigation of Prognostic Biomarkers, Host Factors and Viral Factors for COVID-19 in Children

Role: collaborator

NCT05190055Not ApplicableUnknown

Evaluation of Treatment Effect of Minimally Invasive Spinal Fusion Surgery

Role: lead

NCT05136573Not ApplicableUnknown

Exercises on CIPN, Fatigue, and Quality of Life in Colon Cancer Patients Receiving Chemotherapy

Role: lead

NCT03042520Unknown

Long-term Outcomes of Chronic Hepatitis C Patients Post Sofosbuvir-based Treatment

Role: collaborator

NCT04272177Not ApplicableCompleted

Influence of Shared-Decision Making in Reducing Decision Conflict on the Choice of Awakening Agent After General Anesthesia

Role: collaborator

NCT04712058Not ApplicableUnknown

Same-day Antiretroviral Therapy With BIC/F/TAF

Role: collaborator

NCT03425994Unknown

Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment for HIV/HBV-coinfection

Role: collaborator

NCT03719222Unknown

Analysis of Tumor Mutations and Tumor Microenvironment Using Archival Paraffin-embedded Tumor Specimens

Role: collaborator

NCT02376894Completed

An Epidemiological Survey of Cancer-related Fatigue Among Taiwanese Cancer Patients

Role: collaborator